To evaluate the relationship between tumor immune microenvironment and the deletion of RAPGEF2, we analyze the different evaluation indicators, like the recruitment of immune cell, TMB, TIDE, and the response for the immunotherapy. Here, RAPGEF2 is linked to neoplasm.